Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus
Suciu-Foca, N.; Buda, J.A.; Thiem, T.; Reemtsma, K.
Clinical and Experimental Immunology 18(3): 295-301
1974
ISSN/ISBN: 0009-9104 PMID: 4283364 Document Number: 80253
Document emailed within 1 workday
Related Documents
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222Lima, D.S.N.; Sato, E.I.; Lima, V.C.; Miranda, F.; Hatta, F.H. 2002: Brachial endothelial function is impaired in patients with systemic lupus erythematosus Journal of Rheumatology 29(2): 292-297
Nesterenko, G.B.; Kogon, G.K.; Bashmakov, G.V.; Ploskaia, L.M.; Didenko, I.G. 1981: Nonspecific defense mechanisms and immune responsiveness in patients with eczema, systemic lupus erythematosus, psoriasis and dermatitis medicamentosa Vestnik Dermatologii i Venerologii 3: 21-24
Hari Kumar, M.K.; Knight, R.A.; Snaith, M.L. 1984: Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus Clinical and Experimental Immunology 58(1): 21-28
Stanislav, M.L.; Balabanova, R.M.; Nikonova, M.F.; Litvina, M.M.; Iarilin, A.A. 2000: Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus Terapevticheskii Arkhiv 72(5): 44-49
Hernández-Fuentes, M.P.; Reyes, E.; Prieto, A.; Zea, A.; Villa, L.; Sánchez-Atrio, A.; Esquivel, F.; Alvarez-Mon, M. 1999: Defective proliferative response of T lymphocytes from patients with inactive systemic lupus erythematosus Journal of Rheumatology 26(7): 1518-1526
Wong, H.K.; Kammer, G.M.; Dennis, G.; Tsokos, G.C. 1999: Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression Journal of Immunology 163(3): 1682-1689
Michalevicz, R.; Many, A.; Ramot, B.; Trainin, N. 1978: The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients Clinical and Experimental Immunology 31(1): 111-115
Horwitz, D.A.; Juul-Nielsen, K. 1977: Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells Clinical and Experimental Immunology 30(3): 370-378
Chan, E.Y.; Ko, S.C.; Lau, C.S. 1997: Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus Asian Pacific Journal of Allergy and Immunology 15(1): 3-7
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Tsuchiya, N.; Mitamura, T.; Goto, M.; Moroi, Y.; Kinoshita, M.; Yokohari, R.; Miyamoto, T. 1988: 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells Journal of Rheumatology 15(6): 946-951
Smith, H.R.; Olson, R.R. 1990: CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis Journal of Rheumatology 17(6): 833-835
Patoria, N.K. 1974: Toxicity of systemic lupus erythematosus lymphocytes to human cell cultures Journal of Postgraduate Medicine 20(3): 137-141
Leong, K.P.; Tee, N.W.; Yap, W.M.; Chee, T.S.; Koh, E.T. 2000: Nocardiosis in patients with systemic lupus erythematosus. the Singapore Lupus Study Group Journal of Rheumatology 27(5): 1306-1312
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Timeskov, I.S.; Chirkina, S.S.; Dolgobvorova, K.F.; Gil'fanov, R.N.; Zhuravleva, S.I. 1979: Evaluation of work capacity of patients with systemic lupus erythematosus and systemic scleroderma Terapevticheskii Arkhiv 51(1): 68-71
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924